Erratum: How to treat that nasty itch (Experimental Dermatology (2005) vol. 14 (225-240))

Experimental Dermatology

Volumn 14, Issue 6, 2005, Pages 478-479

  Yosipovitch, Gil ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR; DERMATOLOGY; HUMAN; IMMUNE SYSTEM; NERVOUS SYSTEM; NEUROSECRETION; NOTE; PATHOPHYSIOLOGY; PRURITUS;

DERMATOLOGY; HUMANS; IMMUNE SYSTEM; NERVOUS SYSTEM; NEUROSECRETORY SYSTEMS; PRURITUS;

EID: 23044474375     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2005.0331b.x     Document Type: Erratum

References (17)

1. Yosipovitch G, Greaves M W. Definitions of Itch. In: Yosipovitch G, Greaves M, Fleischer A B, McGlone F, eds. Itch Basic Mechanisms Therapy, NY: Marcel Dekker, 2004: pp 1-4.
2. Yosipovitch G, Greaves M W, Schemlz M. Itch. Lancet 2003: 22 (361): 690-694.
3. Hundley J L, Yosipovitch G. Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study. J Am Acad Dermatol 2004: 50: 889-891.
4. Davis M P, Frandsen J L, Walsh D, Andresen S, Taylor S J. Mirtazapine for pruritus. Pain Symptom Manage 2003: 25: 288-291.
5. Daly B M, Shuster S. Antipruritic action of thalidomide. Acta Derm Venereol 2000: 80: 24-25.
6. Maurer T, Poncelet A, Berger T. Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: efficacy and risk of neuropathy. Arch Dermatol 2004: 140: 845-849.
7. Breuer-McHam J N, Marshall G D, Lewis D E, Duvic M. Distinct serum cytokines in AIDS-related skin diseases. Viral Immunol 1998: 11: 215-220.
8. Nilsson H J, Psouni E, Schouenborg J. Long term depression of human nociceptive skin senses induced by thin fibre stimulation. Eur J Pain 2003: 7 (3): 225-233.
9. Rukweid R, Dvorak M, Watkinson A, McGlone F. Putative role of cannabinoids in experimentally induced itch and inflammation in human skin. In: Yosipovitch G, Greaves M, Fleischer A B, McGlone F, eds. Itch Basic Mechanisms Therapy, NY: Marcel Dekker 2004: pp 115-130.
10. Steinhoff M, Neisius U, Ikoma A, et al. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 2003: 23: 6176-6180.
11. Ui H, Andoh T, Nojima H, Kuraishi Y. Inhibition by serine protease inhibitor Nafamostat Mesilate of itch - associated responses to compound 48/80 in mice. 2nd International Workshop for the Study of Itch, Toyoma, Japan, 2003, pp 69. (Abstract)
12. Hachem J P, Crumrine D, Fluhr J. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 2003: 121: 345-353.
13. Bergasa N V. An approach to the management of the pruritus of cholestasis. Clin Liver Dis 2004: 8: 55-66.
14. Kumagai H, Maruyama S, Gejyo F, Ebata T, Takamori K. Role of Mu- and Kappa opioid systems in systemic and peripheral itch and effects of a novel Kappa agonist TRK 820. In: Kuraishi Y, Nojima H, eds. 2nd International Workshop for the Study of Itch, Toyoma, Japan, 2003, pp 23-24.
15. Bueller H A, Bernhard J D, Dubroff L M. Gabapentin treatment for brachioradial pruritus. J Eur Acad Dermatol Venereol 1999: 13: 227-228.
16. Winhoven S M, Coulson I H, Bottomley W W. Brachioradial pruritus: response to treatment with gabapentin. Br J Dermatol 2004: 150: 786-787.
17. Gieler U, Niemeier V, Kupfer J. Psychosomatic aspects of pruritus. In: Yosipovitch G, Greaves M, Fleischer A B, McGlone F, eds. Itch Basic Mechanisms Therapy. NY: Marcel Dekker 2004: pp 343-349.